Oxaliplatin
NCT02288195
Phase 3 small_molecule active
Quick answer
Oxaliplatin for Rectal Neoplasms is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Rectal Neoplasms
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active